Cetera Investment Advisers’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Sell |
20,398
-720
| -3% | -$46.2K | ﹤0.01% | 2156 |
|
|
2025
Q1 | $1.34M | Sell |
21,118
-1,992
| -9% | -$126K | ﹤0.01% | 2036 |
|
|
2024
Q4 | $1.54M | Sell |
23,110
-547
| -2% | -$36.4K | ﹤0.01% | 1847 |
|
|
2024
Q3 | $1.65M | Sell |
23,657
-4,236
| -15% | -$296K | ﹤0.01% | 1763 |
|
|
2024
Q2 | $1.81M | Buy |
27,893
+561
| +2% | +$36.4K | ﹤0.01% | 1644 |
|
|
2024
Q1 | $1.77M | Buy |
27,332
+14,271
| +109% | +$924K | ﹤0.01% | 1641 |
|
|
2023
Q4 | $860K | Buy |
13,061
+1,370
| +12% | +$90.2K | 0.01% | 1191 |
|
|
2023
Q3 | $667K | Buy |
11,691
+758
| +7% | +$43.2K | 0.01% | 1274 |
|
|
2023
Q2 | $670K | Buy |
10,933
+3,761
| +52% | +$231K | 0.01% | 1288 |
|
|
2023
Q1 | $450K | Buy |
7,172
+1,683
| +31% | +$106K | ﹤0.01% | 1486 |
|
|
2022
Q4 | $349K | Buy |
+5,489
| New | +$349K | ﹤0.01% | 1566 |
|